Premium
The Effects of Bifidobacterium breve Administration on Campylobacter Enteritis
Author(s) -
Tojo Masahiro,
Oikawa Tadao,
Morikawa Yoshiyuki,
Yamashita Naoya,
Iwata Satoshi,
Satoh Yoshitake,
Hanada Juhei,
Tanaka Ryuichiro
Publication year - 1987
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/j.1442-200x.1987.tb00024.x
Subject(s) - bifidobacterium breve , medicine , campylobacter , enteritis , campylobacter jejuni , diarrhea , bifidobacterium , microbiology and biotechnology , carriage , feces , erythromycin , gastroenterology , antibiotics , lactobacillus , bacteria , biology , genetics , pathology
We studied the effects of Bifidobacterium breve on Campylobacter enteritis. Patients with Campylobacter enteritis were divided into three groups (I. Erythromycin recipients; II. B. breve recipients; III. control) and studied with regard to the duration of diarrhea and carriage of Campylobacter jejuni in the stools. Additional studies were performed to observe the effects of B. breve on fecal flora. The results showed that there were no significant differences in the duration of diarrhea among the three groups. Comparison of the duration of C. jejuni carriage in the stools was as follows: KIKIII (P<0.01). Microbiological study of fecal flora demonstrated that the number of bifidobacterium was decreased in Campylobacter enteritis compared to the control, and an increase in the number of bifidobacterium could be recognized after the administration of B. breve. B. breve was useful in eradicating C. jejuni from the stools and restoring the normal intestinal flora in Campylobacter enteritis, although if was not effective in shortening the duration of diarrhea.